Dr Christopher Zishiri.

Int J Tuberc Lung Dis

Epidemiology Group, Woolcock Institute of Medical Research, Sydney, NSW, Australia, Respiratory Medicine, Liverpool Hospital, Sydney, NSW, Australia.

Published: November 2022

Download full-text PDF

Source
http://dx.doi.org/10.5588/ijtld.22.0401DOI Listing

Publication Analysis

Top Keywords

christopher zishiri
4
christopher
1

Similar Publications

Article Synopsis
  • * A study conducted from October 2020 to January 2021 involved 514 ASMs, revealing that 11.2% were diagnosed with silicosis, and 4.0% with TB, while 23.5% of those tested for HIV were sero-positive.
  • * The study highlights a critical need for improved occupational health services for ASMs, emphasizing the importance of TB and silicosis surveillance, although these findings are preliminary and require further research for validation.
View Article and Find Full Text PDF

Globally, childhood tuberculosis (TB among those aged <15 years) is a neglected component of national TB programmes in high TB burden countries. Zimbabwe, a country in southern Africa, is a high burden country for TB, TB-HIV, and drug-resistant TB. In this study, we assessed trends in annual childhood TB notifications in Harare (the capital of Zimbabwe) from 2009 to 2018 and the demographic, clinical profiles, and treatment outcomes of childhood TB patients notified from 2015-2017 by reviewing the national TB programme records and reports.

View Article and Find Full Text PDF

Background: Zimbabwe is one of the thirty countries globally with a high burden of multidrug-resistant tuberculosis (TB) or rifampicin-resistant TB (MDR/RR-TB). Since 2010, patients diagnosed with MDR/RR-TB are being treated with 20-24 months of standardized second-line drugs (SLDs). The profile, management and factors associated with unfavourable treatment outcomes of MDR/RR TB have not been systematically evaluated in Zimbabwe.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!